00:11 , Dec 2, 2017 |  BC Extra  |  Financial News

Athyrium, Neuberger close $2B third fund

Athyrium Capital Management and Neuberger Berman closed Athyrium Opportunities Fund III at $2.025 billion. The new fund will make investments in commercial-stage companies across the healthcare ecosystem, with more than 50% of the capital expected...
00:06 , Dec 2, 2017 |  BioCentury  |  Finance

Opportunity sizing

With strong support from existing and new LPs and an attractively priced healthcare sector to play in, Athyrium Capital Management and Neuberger Berman went big for their third co-managed fund. Athyrium Opportunities Fund III clocked...
07:00 , Jul 27, 2015 |  BC Week In Review  |  Financial News

Athyrium Capital Management financial update

Athyrium Capital Management , New York, N.Y.   Business: Finance   Date announced: 2015-07-20   Note: Athyrium Capital Management and partner Neuberger Berman closed a $1.2 billion fund that will invest in commercial stage healthcare...
07:00 , Jul 27, 2015 |  BioCentury  |  Finance

Athyrium doubles down

Athyrium Capital Management expects its newly closed $1.2 billion fund has found the sweet spot for infusing structured capital into commercial-stage healthcare companies. Athyrium and partner Neuberger Berman closed their first fund, Athyrium Opportunities Fund...
00:46 , Jul 21, 2015 |  BC Extra  |  Financial News

Athyrium, Neuberger close $1.2B fund

Athyrium Capital Management and partner Neuberger Berman closed a $1.2 billion fund that will invest in commercial stage healthcare companies. The fund, Athyrium Opportunities Fund II, plans to make about 20 investments, each ranging from...
07:00 , Aug 19, 2013 |  BioCentury  |  Finance

Private equity tracks

Private equity tracks David Pinniger joined Polar Capital as a biotechnology fund manager. He was an investment manager for the International Biotechnology Trust at SV Life Sciences. Jeremy Lack joined Athyrium Capital as a partner....
07:00 , May 27, 2013 |  BC Week In Review  |  Financial News

Athyrium Capital Management LLC, Neuberger Berman Group LLC financial update

Athyrium Capital and Neuberger Berman closed a life sciences private credit fund, Athyrium Opportunities Fund L.P., at $507 million, well above the original target of $350 million. The fund, which the partners formed in 2011,...
07:00 , May 27, 2013 |  BioCentury  |  Finance

Autologous monetization

While the equity markets have clear appetite for new biotech paper, the oversubscribed Athyrium Opportunities Fund L.P. shows investors are not turning a blind eye to alternative financing vehicles. Athyrium Capital Management and partner Neuberger...
00:23 , May 21, 2013 |  BC Extra  |  Financial News

Athyrium, Neuberger close $507M fund

Athyrium Capital Management and partner Neuberger Berman closed a life sciences private credit fund, Athyrium Opportunities Fund L.P., at $507 million, well above the original target of $350 million. The fund, which the partners formed...
07:00 , May 6, 2013 |  BC Week In Review  |  Financial News

BioFire completes venture financing

BioFire Diagnostics Inc. , Salt Lake City, Utah   Business: Diagnostic, Supply/Service   Date completed: 5/2/13   Type: Venture financing   Raised: $20 million   Investor: Athyrium Opportunities Fund  ...